Stimulant therapy

DRUG2 trials

Sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc., JPM van Stralen Medicine Professional

Conditions

Attention Deficit Hyperactivity Disorder

Phase 2

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

CompletedNCT01074294

Otsuka Pharmaceutical Development & Commercialization, Inc.Attention Deficit Hyperactivity Disorder

Start: 2010-03-16End: 2011-06-20Updated: 2023-02-02

Phase 4

Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD

CompletedNCT01985581

JPM van Stralen Medicine ProfessionalAttention Deficit Hyperactivity Disorder

Start: 2013-10-31End: 2015-03-31Updated: 2016-05-23